Skip to main content

Table 5 Averages and standard deviation, daily IL-2 mono-therapy

From: Fine-tuning anti-tumor immunotherapies via stochastic simulations

〈t er 〉

σ

〈t er 〉

σ

19.34

0.33

22.71

0.41

  1. Daily delivered IL-2 immunotherapy. Average of t er and its standard deviation σ evaluated for the piece-wise constant (left) and impulsive (right) therapies of Figure 6.